TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells-Reference-Cited by-同舟云学术

TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells

Published:2014-05-26 Issue:12 Volume:42 Page:7819-7832
ISSN:0305-1048
Container-title:Nucleic Acids Research
language:en
Short-container-title:Nucleic Acids Res

Author:

Liang Xue-hai,Shen Wen,Sun Hong,Prakash Thazha P.,Crooke Stanley T.

Publisher

Oxford University Press (OUP)

Subject

Genetics

Link

http://academic.oup.com/nar/article-pdf/42/12/7819/3885383/gku484.pdf

Reference40 articles.

1. Disease-targeted sequencing: a cornerstone in the clinic

2. Crooke S.T. Vickers T. Lima W. Wu H.-J. Mechanisms of antisense drug action, an introduction. In: Crooke ST , editor. Antisense Drug Technology—Principles, Strategies, and Application . Boca Raton, FL: CRC Press; 2006. p. 3-46.

3. Bennett C.F. Pharmacological properties of 2'-O-methyoxyethyl-modified oligonucleotides. In: Crooke ST , editor. Antisense Drug Technology—Principles, Strategies, and Applications . Boca Raton, FL: CRC Press; 2006. p. 273-304.

4. Emerging LDL therapies: Mipomersen—antisense oligonucleotide therapy in the management of hypercholesterolemia

5. Dias N. Stein C.A. Antisense oligonucleotides: basic concepts and mechanisms. Mol. Cancer Ther. 2002;1:347-355.

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases;BioDrugs;2024-01-22

2. High-resolution visualisation of antisense oligonucleotide release from polymers in cells;Chemical Science;2024

3. Characterization of cooperative PS-oligo activation of human TLR9;Molecular Therapy - Nucleic Acids;2023-09

4. Enhancing the Effectiveness of Oligonucleotide Therapeutics Using Cell-Penetrating Peptide Conjugation, Chemical Modification, and Carrier-Based Delivery Strategies;Pharmaceutics;2023-04-03

5. MiRNAs Overexpression and Their Role in Breast Cancer: Implications for Cancer Therapeutics;Current Drug Targets;2023-04